CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

cardamine

07/31/2025 7:52:12 PM

(fwiw: "While specific adverse event (3)

Figgs

07/31/2025 2:27:06 PM

Could Leronlimab be used as a longevity (5)

Evil Rabbit

07/31/2025 1:18:01 PM

Hey Riz (NOMOD), Youve been told by (26)

dfwl28

07/31/2025 12:46:45 PM

IL-6 cytokine -slow day "...Unlike

enemyofpluto

07/30/2025 8:55:53 PM

1,750 million IS 1.75B. (7)

bbqbbq

07/30/2025 7:23:49 PM

Garry Nolan's role with the CCR5 (6)

misiu143

07/30/2025 3:54:40 PM

It is not always easy , her doctor in a (8)

ohm20

07/30/2025 3:48:55 PM

Dr Jay do not give RTT or (11)

misiu143

07/30/2025 3:34:38 PM

Not always that easy to get IRB. Friend (5)

sean007

07/30/2025 3:29:10 PM

The FDA approves over 99% of ALL (12)

misiu143

07/30/2025 2:00:30 PM

Dr Jay do not give RTT or (16)

NOMOD

07/30/2025 9:10:47 AM

Youre very welcome. Youre doing (7)

cardamine

07/30/2025 1:30:00 AM

Thank you for writing all this out--it (3)

NOMOD

07/30/2025 1:08:21 AM

I cant PM, so feel free to email me (20)

cardamine

07/30/2025 12:50:56 AM

Quick Question re right to (5)

sjacobs26

07/29/2025 4:37:59 PM

Just doing a quick comparisonCELC (21)

cardamine

07/29/2025 3:23:29 PM

still as of yesterday, only approx 12

MidnightRider

07/29/2025 3:17:38 PM

From Reddit yesterday : r/Livimmune (8)

Katangolo

07/29/2025 11:45:29 AM

Yes, mitochondrial dysfunction, Golgi (2)

Katangolo

07/29/2025 11:44:14 AM

Amen. Youre dialed (4)

Katangolo

07/29/2025 11:42:55 AM

Crp, iL-6, pd1 anything involved in (8)

craigakess

07/29/2025 10:27:19 AM

I think you might mean 1.75 billion (2)

MIM-104

07/29/2025 7:20:17 AM

You can read this in detail via this (3)

docj

07/29/2025 7:11:27 AM

1,750 million authorized shares of (2)

ohm20

07/29/2025 1:31:17 AM

IHUB is currently under federal watch (16)

ohm20

07/29/2025 1:22:34 AM

There is one obvious bio-marker, or end (20)

Figgs

07/28/2025 10:59:35 PM

Took long weekend to Canada. Nice (2)

My69z

07/28/2025 10:43:02 PM

Deals for Phase 1 have brought $1b+. (10)

JmcII

07/28/2025 10:19:04 PM

Does anyone know our total shares

sunray3

07/28/2025 7:32:47 PM

I'm sure you're right, there are going

Mr3Putt

07/28/2025 7:25:01 PM

2025-07-24 * Study Status * Arms and (1)

Evil Rabbit

07/28/2025 7:16:25 PM

Clinictrials.gov is always late to be (2)

Buddyboy20

07/28/2025 6:52:03 PM

Two study locations? (1)

Mr3Putt

07/28/2025 6:40:22 PM

updates posted to CRC trial: (7)

sherlock57

07/28/2025 4:46:46 PM

"Since we are doing a clinical trial, (12)

sunray3

07/28/2025 12:02:02 PM

If so (not doubting you) then not (8)

Buddyboy20

07/28/2025 11:25:09 AM

I can almost guarantee that his (2)

sunray3

07/28/2025 11:18:19 AM

Thanks for the update on Dr C's (7)

Buddyboy20

07/28/2025 10:00:14 AM

It has been over one year that Dr Chan (22)

Mr3Putt

07/28/2025 9:48:14 AM

Your question is answered precisely (2)

SaltyMutt

07/28/2025 7:51:21 AM

Does this one fly soon? (1)

bbqbbq

07/27/2025 10:12:45 PM

Garry Nolan is a prominent immunologist (4)

My69z

07/27/2025 8:33:43 PM

Reason for S3's is being overlooked --- (5)

sean007

07/27/2025 6:59:58 PM

You can believe with Tanya at the (10)

USS JOHNSTON

07/27/2025 5:09:10 PM

Thanks, 3Putt, that discussion on (7)

ohm20

07/27/2025 5:03:55 PM

Upwithstock to the rescue: As I said (13)

sean007

07/27/2025 3:47:06 PM

"The Shelf offering"...shows We have a (5)

Mr3Putt

07/27/2025 3:21:58 PM

Upwithstock to the rescue: (13)

USS JOHNSTON

07/27/2025 2:54:06 PM

I'd like to hear from business-savvy (1)

sean007

07/27/2025 2:41:17 PM

I am neither a monitor or a (1)

Newer

Older

Recent Articles

• Melexis Reports Exciting Q3 2025 Financial Performance
• WISeKey and INNOSPACE Join Forces for Next-Gen Satellite Launches
• Corbion Reports Remarkable Growth and Maintains Full Year Outlook
• Addex Expands Share Capital for Future Financial Flexibility
• Telenor's Robust Q3 Performance Amid Global Challenges
• Subsea 7 S.A. Declares NOK 6.50 Dividend for Investors
• Roche's New Dengue Test Boosts Diagnosis and Efficiency
• Equinor's Robust Q3 Performance and Strategic Initiatives for Growth
• Equinor ASA Updates on Dividend Details for Upcoming Year
• Equinor Launches Final Buy-Back Tranche for 2025 Programme
• Equinor Reports Strong Third Quarter Results for 2025
• BlueNord's Impressive Q3 2025 Financial Performance Revealed
• Tesla's Cybercab: Embracing Traditional Features for Success
• Optimism Prevails as Nasdaq Reaches New Heights with Earnings
• KBR, Inc. Faces Securities Class Action Amid Allegations
• NCS Achieves Prestigious Recognition for AI Innovation Excellence
• Important Updates on RCI Hospitality Holdings Securities Lawsuit
• Hepsor AS Reports Strong Q3 2025 Financial Performance
• Fortinet, Inc. Faces Class Action Over Alleged Securities Fraud
• Levi & Korsinsky Clarifies Details on Fluor Class Action Lawsuit
• Savara Inc. Faces Class Action for Securities Fraud Claims
• GTreasury's Recognition as Premier TMS Provider in APAC
• Skyline Builders Group Secures $23.9 Million Funding for Growth
• Stocks to Monitor this Week: Key Insights and Trends
• VSee Health Experiences Significant Stock Surge After Approval
• Innovative Prematurity Research Center Debuts in Texas
• Microsoft's Bold Leap with OpenAI Turns into a Lucrative Venture
• Solana, Litecoin, and Hedera Struggle Amid ETF Launch Hype
• Lyocell Market Expected Growth to $3.3 Billion by 2034
• MGI Tech Strengthens Global Position with Exclusive Deal
• MGI Tech Partners with Swiss Rockets to Advance Sequencing Tech
• How Young Consumers Are Shaping the Future of Fashion
• Cogna Educação S.A. Extends Tender Offer for Vasta Shares
• LUMAS K.K. Unveils Cutting-Edge NVA at Blechexpo 2025 Event
• GAC Celebrates Brand Debut in the Caribbean, Expanding Reach
• Mazda Unveils Innovative Vision Models at Mobility Show 2025
• Class Action Filed Against Korn Ferry ISP for Employee Rights
• Nokia's Stock Surge Linked to Nvidia's Strategic Investment
• Simon Yueng Earns KPMG Award for Family Business Excellence
• The Unstoppable Call for National Reunification in China
• Nvidia's CEO Advocates for Global Developer Collaboration in AI
• Stock Highlights: Nvidia, Nokia, Bloom Energy, Visa, and Cameco
• Legal Action Initiated by Blumenthal Nordrehaug Bhowmik De Blouw LLP
• Rent the Runway Enhances Financial Stability with New Deal
• Cryptocurrency Trends Amid Rate Speculation and Market Movements
• Important Legal Update: Fluor Corporation Faces Class Action
• VUNO Expands European Reach with Strategic Partnerships
• Important Updates on Fortinet Inc. Securities Fraud Lawsuit
• Important Update for Fluor Corporation Shareholders
• Key Legal Update for Cytokinetics Investors on Class Action